ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as they’re published. Senators introduced legislation on Thursday that would ...

LBL-034, a GPRC5D/CD3 bispecific antibody, was developed using the proprietary LeadsBody platform, featuring a unique two-to-one structure and conditional activation. Fast track designation offers ...

** When you buy products through the links on our site, we may earn a commission that supports NRA's mission to protect, preserve and defend the Second Amendment. ** The Red Label III marks the third ...

It’s well known that we use imperfect mental shortcuts—and sometimes, unfair stereotypes—to determine who’s trustworthy, who’s talented, and who can join a group. Luckily, research continues to ...

The best label maker is a boost to your storage and organization efforts, whether that’s sorting a spice rack or slapping your kid’s name on their back-to-school stuff. It makes closets and drawers ...

JavaFX isn't hard to learn. In fact, any developer with a little bit of object-oriented knowledge and a penchant for desktop development in Java can quickly put together a feature-rich GUI application ...

On Windows 11, you can display labels for apps in the Taskbar, and in this guide, I'll walk you through how to enable this configuration quickly and easily. In earlier versions of the operating system ...

How consumers define ‘clean label’ is expanding beyond ‘simple, easy-to-understand ingredients’ to include questions about the safety of some long-used ingredients and processing techniques as well as ...

The key difference between Swing vs. JavaFX is that JavaFX is an actively maintained Java project that supports the development of modern, feature-rich GUI applications, while Swing is an older ...

LBL-034 is an investigational GPRC5D-targeted CD3 bispecific antibody. The Food and Drug Administration (FDA) has granted Orphan Drug designation to LBL-034 for the treatment of multiple myeloma.

Leads Biolabs grants Oblenio Bio an exclusive option to license LBL-051, a first-in-class CD19xBCMAxCD3 tri-specific T-cell engager antibody OAKLAND, Calif. and NANJING, China, Nov. 7, 2024 ...

A potential FDA proposal would label Goldfish “medium” in saturated fat and sodium. (The placement and size of any U.S. label has yet to be determined.) The same product would bear stop-sign-shaped ...